Company Name, Ticker, Suppliers, else..
STOCKS
HOME
Stock Profile
Company Fundamentals
Financial Results
PETX's Officers & Directors
Company Descriptions
Charts & Quotes
News
Company Suppliers
Company Competitors
Company Markets Customers
Economic Indicators
INDUSTRIES
Revenue Growth by Industry
Net Income Growth by Industry
Net Margin by Industry
PE by Industry
Total Debt to Equity by Industry
Revenue per Employee by Industry
Return On Assets by Industry
Performance by Industry
Growth Rates by Industry
Profitability by Industry
Valuation by Industry
Financial Strength by Industry
ECONOMY
Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
U.S. International Trade
Factory orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
MARKETS
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
SCREENING
Stock Performance Screening
Profitability Screening
Valuation Screening
Dividend Screening
Financial Strength Screening
Efficiency Screening
Largest Companies
Mgmnt. Effectivness Screening
NEWS
Stock News
Economy News
GLOSSARY
Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
HELP
Company Profile
Aratana Therapeutics, Inc. News
Aratana Therapeutics, Inc.'s Effective Tax Rate
Aratana Therapeutics, Inc.'s Price to sales ratio PS
Aratana Therapeutics, Inc. Business Description
Aratana Therapeutics, Inc. Executive Officers
Economic Indicators
Fundamentals
Aratana Therapeutics, Inc. Growth Rates
Aratana Therapeutics, Inc. Profitability
Aratana Therapeutics, Inc. Valuation
Aratana Therapeutics, Inc. Management Effectiveness
Aratana Therapeutics, Inc. Financial Strength
Aratana Therapeutics, Inc. Efficiency
Aratana Therapeutics, Inc. Dividend
Financials
Aratana Therapeutics, Inc. Business Segments
Aratana Therapeutics, Inc. Income Statement
Aratana Therapeutics, Inc. Balance Sheets
Aratana Therapeutics, Inc. Cash Flow Statement
Aratana Therapeutics, Inc. Geographic Information
Suppliers
Aratana Therapeutics, Inc. Suppliers Performance
PETX Suppliers Stock Performance
PETX Suppliers Growth Rates
PETX Suppliers Data
PETX Suppliers Efficiency
PETX Suppliers Management Effectiveness
PETX Suppliers Valuation
PETX Suppliers by Companys' Segments
Competition
Competition by Companys' Segments
Aratana Therapeutics, Inc. Market Share
Aratana Therapeutics, Inc. Competition Performance
Aratana Therapeutics, Inc. Competitors Results
PETX Competitors Stock Performance
PETX Competitors Growth Rates
PETX Workforce Efficiency at the Competitors
PETX Competitors Efficiency
PETX Competitors Management Effectiveness
PETX Competitors Valuation
Customers & Markets
Aratana Therapeutics, Inc. Customers Demand
PETX Customers Expenditure Growth Rates
PETX Customers Performance
PETX Customers Stock Performance
PETX Customers Growth Rates
PETX Workforce Efficiency at the Customers
PETX Customers Efficiency
PETX Customers Management Effectiveness
PETX Customers Valuation
PETX Customers by Companys' Segments
Charts & Quotes
Aratana Therapeutics, Inc. Comparison Charts
PETX OHLC Charts
PETX's Tehnical Upper Indicators
PETX's Tehnical Lower Indicators
PETX's Weekly Charts
PETX's Monthly Charts
Aratana Therapeutics, Inc.'s Profile
Company Charts and Quotes
Aratana Therapeutics, Inc. News
Aratana Therapeutics, Inc.'s Executive Officers
Aratana Therapeutics, Inc.'s Income Statement
Aratana Therapeutics, Inc.'s Balance Sheets
Aratana Therapeutics, Inc.'s Cash Flow Statement
Aratana Therapeutics, Inc.'s Profitability
Aratana Therapeutics, Inc.'s Financials
PETX's Interest Coverage Ratio
Aratana Therapeutics, Inc.'s Suppliers
Aratana Therapeutics, Inc.'s Competitors
Aratana Therapeutics, Inc.'s Markets & Customers
Aratana Therapeutics, Inc.'s Market Share
PETX's Suppliers Valuation
PETX's Competitors Efficiency
PETX's Charts Comparison
Aratana Therapeutics, Inc.'s Customers Expenditure Growth Rates
Economic Indicators
Profitability by Industry
Valuation Screening
Markets at a Glance
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
U.S. International Trade
News
Economy News
Stock News
Financial Terms
At a Glance
Growth Rates
• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• EPS Cop. Y/Y Annual
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Aratana Therapeutics, Inc.
(
PETX
)
Other Ticker:
Sector
•
Healthcare
Industry
•
Major Pharmaceutical Preparations
Industry
•
Major Pharmaceutical Preparations
Sector
•
Healthcare
Aratana Therapeutics's Yearly EPS from Cont. Operations Growth 5 Years
Select the Comparisons :
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Select the Ratio:
Annual EPS from Cont. Operations Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Annual EPS from Cont. Operations Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
PETX Annual EPS from Cont. Operations Growth
2018
2017
2015
2014
2013
Y / Y Annual EPS from Cont. Operations Change
-
-
-
-
-
Annual EPS from Cont. Operations (in $)
$-0.32
$-1.17
$-2.45
$-1.30
$-0.39
PETX Company Profile
>>
Back to PETX Fundamentals at a Glance
>>
Back to PETX Growth Comparisons
Annual EPS from Cont. Operations Growth Comment
Aratana Therapeutics Annual Income Statement
You need to upgrade your Flash Player
Companies with similar 2018 Annual EPS from Cont. Operations within Healthcare Sector
Y/Y EPS from Cont. Operations Growth %
2018 Annual EPS from Cont. Operations
Zimmer Biomet Holdings Inc